The increase in ROS in A375 cells after TGF-β1 downregulation was likely triggered by a decrease in tumor-promoting non-canonical Akt activation25,74 mediated by NOX4 expression rather than by the canonical Smad signaling pathway, which is also known to have a tumor-promoting role75. Here, AKT1 is linked to neoplasm.